SCHEMBL4032550

SCHEMBL4032550

C(=N/Cc1cc(-c2cccnc2)no1)\c1ccccc1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2C9 P11712 3/20 0.58
CYP2C19 P33261 3/20 0.58
CYP2E1 P05181 1/20 0.58
CYP2A6 P11509 1/20 0.58
CYP2B6 P20813 1/20 0.58
CA12 O43570 1/20 0.46
CA9 Q16790 1/20 0.46
RAB9A P51151 6/20 0.44
NPC1 O15118 5/20 0.44
NOTUM Q6P988 2/20 0.43
SMN1; SMN2 Q16637 6/20 0.42
TP53 P04637 2/20 0.42
CYP11B1 P15538 3/20 0.41
ALDH1A1 P00352 3/20 0.41
CYP11B2 P19099 2/20 0.41
MEN1 O00255 1/20 0.41
CASP3 P42574 1/20 0.41
KMT2A Q03164 1/20 0.41
SENP8 Q96LD8 1/20 0.41
SENP7 Q9BQF6 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4032553 1.00 CYP2C9 (0.58) CYP2C9CYP2C19CYP2E1CYP2A6CYP2B6
SCHEMBL3852793 0.78 CA12 (0.42) CYP2C9CYP2C19CA12CA9RAB9A
SCHEMBL3852796 0.78 CA12 (0.42) CYP2C9CYP2C19CA12CA9RAB9A
SCHEMBL27163520 0.74 CYP2A6 (0.72) CYP2C9CYP2C19CYP2E1CYP2A6CYP2B6
SCHEMBL2121672 0.74 CYP2A6 (1.00) CYP2C9CYP2C19CYP2E1CYP2A6CYP2B6
SCHEMBL2305968 0.74 CYP2A6 (0.72) CYP2C9CYP2C19CYP2E1CYP2A6CYP2B6
SCHEMBL10162470 0.74 CYP2A6 (0.72) CYP2C9CYP2C19CYP2E1CYP2A6CYP2B6
SCHEMBL22195036 0.73 CYP2C9 (0.67) CYP2C9CYP2C19CYP2E1CYP2A6CYP2B6
SCHEMBL3852601 0.73 NPC1 (0.38) CA12RAB9ANPC1SMN1; SMN2TP53
SCHEMBL3852598 0.73 NPC1 (0.38) CA12RAB9ANPC1SMN1; SMN2TP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1678169-B1 4-(PYRAZOL-3-YLAMINO)PYRIMIDINE DERIVATIVES FOR USE IN THE TREATMENT OF CANCER ASTRAZENECA AB (SE) 2009-07-22 EP disclosed